
Policy Development Working Group
Pharmaceutical Strategy Task Force
Mission: Accelerate Adoption by Healthcare Stakeholders of In Silico Medicine for Bringing New Medicine to Patients


Co-Chair: Cécile De Coster (Alexion)
Co-Chair: Francesco Pappalardo (University of Catania)
Goals
- Address Regulatory Aspects of in silico medicine when used in Pharmaceuticals
- Advocate use of in silico medicine for Pharmaceuticals for stakeholders
- Increase confidence of Industry for use of in silico medicine for Pharmaceuticals
- Identify use of in silico medicine for (specific) target indications and target populations